Please ensure Javascript is enabled for purposes of website accessibility
Fighting COVID-19: Drug Shows Promise in Treating Coronavirus Patients
TLBBHMAP3-U010ALB5ANM-348f959abae2-512-300x300-1
By Jim Jakobs, Digital Producer
Published 5 years ago on
March 27, 2020

Share

Vancouver-based company CytoDyn Inc. shared positive test results on Friday from seven coronavirus patients who were treated with the company’s leronlimab drug at a leading medical center in the New York City area.

Editor’s Note: GV Wire is contacting companies around the world working on medical advancements to combat the COVID-19 pandemic. This is our latest report about efforts to defeat the coronavirus.

Seven Patients With Severe COVID-19 Demonstrate Promise

In a Friday press release sent to GV Wire, the company says leronlimab used in seven patients with severe COVID-19 demonstrated promise. Two patients in ICU were removed and taken off breathing tubes with reduced pulmonary inflammation.
According to the release from CytoDyn, leronlimab is believed to provide “therapeutic benefit by enhancing the immune response while mitigating the ‘cytokine storm’ that leads to morbidity and mortality in these patients.”

CytoDyn CEO Hopeful Leronlimab Will Reduce Mortality Rate

Nader Pourhassan, Ph.D., president and chief executive officer of CytoDyn, said in a news release: “We are extremely pleased for the coronavirus patients under the care of the treating medical team and that the FDA is so responsive to advance our Phase 2 clinical trial. I am very hopeful that leronlimab can help to reduce the rate of mortality among COVID-19 patients with severe symptoms of ARDS and to assist our government to fight this battle.”
Bruce Patterson, M.D., chief executive officer and founder of IncellDx, a diagnostic partner and advisor to CytoDyn, said, “Our companion diagnostics showed that after three days of therapy, the immune profile in these patients approached normal levels and the levels of cytokines involved in the cytokine storm were much improved.”

Watch: Leronlimab Delivers Promising Results

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

Townsizing? Land Snorkeling? A User’s Guide to the Latest Travel Lingo

DON'T MISS

Trump Trade War Has Already Had Huge Effect on California Ports

DON'T MISS

Cambodian American Chefs Are Finding Success and Raising Their Culture’s Profile. On Their Terms

DON'T MISS

Ancient DNA Reveals a New Group of People Who Lived Near Land Bridge Between the Americas

DON'T MISS

FDA Approves Moderna’s New Lower-Dose COVID-19 Vaccine

DON'T MISS

Cabrera, Three Relievers Combine to Lead Marlins to Win Over Giants

DON'T MISS

Spike in Steel Tariffs Could Imperil Trump Promise of Lower Grocery Prices

DON'T MISS

Dodgers’ Mookie Betts Out With Broken Toe After Late-Night Bedroom Mishap

DON'T MISS

California Gubernatorial Candidate Steve Hilton Vows to Repeal Transgender Athlete Law

DON'T MISS

Trans Athlete Competes in California Championships in Clovis Despite National Controversy

UP NEXT

Chronic Stress Linked to Higher Dementia Risk, Experts Warn

UP NEXT

How in the World Did Fresno End Up on Trump’s Sanctuary Cities List?

UP NEXT

Loretta Swit, Emmy-winner Who Played Houlihan on Pioneering TV Series ‘M.A.S.H.,’ Has Died at 87

UP NEXT

Medicaid Work Rules Could Leave a Million Californians With No Health Insurance

UP NEXT

California School Awards Dinner at Disneyland Comes With Hefty Price Tag

UP NEXT

1 in 4 US Children Have Parents With Substance Use Disorder, Study Finds

UP NEXT

Dozens Sickened in Expanding Salmonella Outbreak Linked to Recalled Cucumbers

UP NEXT

Fresno Unified Communications Boss on Leave After AI-Generated FTA Dossier Debacle

UP NEXT

Speaker Johnson Raises Campaign Money in Fresno

UP NEXT

White House Acknowledges Problems in RFK Jr.’s MAHA Report

Ancient DNA Reveals a New Group of People Who Lived Near Land Bridge Between the Americas

23 hours ago

FDA Approves Moderna’s New Lower-Dose COVID-19 Vaccine

2 days ago

Cabrera, Three Relievers Combine to Lead Marlins to Win Over Giants

2 days ago

Spike in Steel Tariffs Could Imperil Trump Promise of Lower Grocery Prices

2 days ago

Dodgers’ Mookie Betts Out With Broken Toe After Late-Night Bedroom Mishap

2 days ago

California Gubernatorial Candidate Steve Hilton Vows to Repeal Transgender Athlete Law

2 days ago

Trans Athlete Competes in California Championships in Clovis Despite National Controversy

2 days ago

Tim Walz Urges Democrats to Fight Back Harder Against ‘Bully’ Trump

2 days ago

US Defense Secretary Warns Indo-Pacific Allies of ‘Imminent’ Threat From China

2 days ago

Hamas Responds to the US Ceasefire Proposal for Gaza While Seeking Amendments

2 days ago

Townsizing? Land Snorkeling? A User’s Guide to the Latest Travel Lingo

For your next trip, have you considered townsizing? What about choosing a detour destination? And instead of forest-bathing, maybe it’...

22 hours ago

22 hours ago

Townsizing? Land Snorkeling? A User’s Guide to the Latest Travel Lingo

22 hours ago

Trump Trade War Has Already Had Huge Effect on California Ports

23 hours ago

Cambodian American Chefs Are Finding Success and Raising Their Culture’s Profile. On Their Terms

23 hours ago

Ancient DNA Reveals a New Group of People Who Lived Near Land Bridge Between the Americas

2 days ago

FDA Approves Moderna’s New Lower-Dose COVID-19 Vaccine

2 days ago

Cabrera, Three Relievers Combine to Lead Marlins to Win Over Giants

2 days ago

Spike in Steel Tariffs Could Imperil Trump Promise of Lower Grocery Prices

2 days ago

Dodgers’ Mookie Betts Out With Broken Toe After Late-Night Bedroom Mishap

Help continue the work that gets you the news that matters most.

Search

Send this to a friend